No fewer than five analysts have lifted their price target in the last week GoodRx Holdings Inc (NASDAQ:GDRX) stock is on the rise today, after an upgrade from RBC to "outperform" from "market perform," with a price-target hike to $10 from$8. This is just the latest in a string of bull notes for the stock, as GDRX has received five price-target hikes since a Raymond James upgrade a week ago. At last glance, GoodRx stock was up 2% at $7.35, earlier as high as$7.80. The equity has been trading choppily, wit ...